Jabil signs deal for pharma device
March 4, 2021 - Jabil Healthcare has secured exclusive rights to develop a high-volume reusable auto-injector after entering a strategic collaboration agreement with global drug delivery device company E3D. The agreement allows Jabil Healthcare to further develop connected auto-injectors for a range of dosing volumes and patient-centric benefits, ultimately creating a platform of devices, a news release said. Jabil Healthcare is a division of Jabil (NYSE: JBL), the largest publicly traded company headquartered in St. Petersburg and in the Tampa-St. Petersburg area.